N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline

C65H72Cl3F3N16O6S3 — CID 159651412

IUPACN-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline
SMILESCS(=O)(=O)N1CCN(c2cc(C(F)(F)F)cc3[nH]ncc23)C2CCCCC21.CS(=O)(=O)N1CCN(c2cc(Cl)cc3[nH]ncc23)C2CCCCC21.CS(=O)(=O)Nc1ccc2c(c1)CCN(c1cc(Cl)cc3[nH]ncc13)C2.Clc1cc(N2CCc3cnccc3C2)c2cn[nH]c2c1
InChIInChI=1S/C17H17ClN4O2S.C17H21F3N4O2S.C16H21ClN4O2S.C15H13ClN4/c1-25(23,24)21-14-3-2-12-10-22(5-4-11(12)6-14)17-8-13(18)7-16-15(17)9-19-20-16;1-27(25,26)24-7-6-23(14-4-2-3-5-15(14)24)16-9-11(17(18,19)20)8-13-12(16)10-21-22-13;1-24(22,23)21-7-6-20(14-4-2-3-5-15(14)21)16-9-11(17)8-13-12(16)10-18-19-13;16-12-5-14-13(8-18-19-14)15(6-12)20-4-2-10-7-17-3-1-11(10)9-20/h2-3,6-9,21H,4-5,10H2,1H3,(H,19,20);8-10,14-15H,2-7H2,1H3,(H,21,22);8-10,14-15H,2-7H2,1H3,(H,18,19);1,3,5-8H,2,4,9H2,(H,18,19)
InChIKeyMRPRBIZQNNYMSI-UHFFFAOYSA-N
MW1432.95 g/mol
LogP11.91
Rot. Bonds8

About N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline

N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline (PubChem CID 159651412) has the molecular formula C65H72Cl3F3N16O6S3 and a molecular weight of 1432.95 g/mol. Its IUPAC name is N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline.

Molecular Properties

Compound NameN-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline
PubChem CID159651412
Molecular FormulaC65H72Cl3F3N16O6S3
Molecular Weight1432.95 g/mol
Exact Mass1430.40
IUPAC NameN-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline
SMILESCS(=O)(=O)N1CCN(c2cc(C(F)(F)F)cc3[nH]ncc23)C2CCCCC21.CS(=O)(=O)N1CCN(c2cc(Cl)cc3[nH]ncc23)C2CCCCC21.CS(=O)(=O)Nc1ccc2c(c1)CCN(c1cc(Cl)cc3[nH]ncc13)C2.Clc1cc(N2CCc3cnccc3C2)c2cn[nH]c2c1
InChIInChI=1S/C17H17ClN4O2S.C17H21F3N4O2S.C16H21ClN4O2S.C15H13ClN4/c1-25(23,24)21-14-3-2-12-10-22(5-4-11(12)6-14)17-8-13(18)7-16-15(17)9-19-20-16;1-27(25,26)24-7-6-23(14-4-2-3-5-15(14)24)16-9-11(17(18,19)20)8-13-12(16)10-21-22-13;1-24(22,23)21-7-6-20(14-4-2-3-5-15(14)21)16-9-11(17)8-13-12(16)10-18-19-13;16-12-5-14-13(8-18-19-14)15(6-12)20-4-2-10-7-17-3-1-11(10)9-20/h2-3,6-9,21H,4-5,10H2,1H3,(H,19,20);8-10,14-15H,2-7H2,1H3,(H,21,22);8-10,14-15H,2-7H2,1H3,(H,18,19);1,3,5-8H,2,4,9H2,(H,18,19)
InChIKeyMRPRBIZQNNYMSI-UHFFFAOYSA-N
XLogP11.91
TPSA261.50 Ų
H-Bond Donors5
H-Bond Acceptors15
Rotatable Bonds8
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001432.95
LogP ≤ 511.91
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1015

Analyze N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline?
The IUPAC name of N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline (CID 159651412) is N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline.
What is the SMILES notation for N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline?
The canonical SMILES for N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline is CS(=O)(=O)N1CCN(c2cc(C(F)(F)F)cc3[nH]ncc23)C2CCCCC21.CS(=O)(=O)N1CCN(c2cc(Cl)cc3[nH]ncc23)C2CCCCC21.CS(=O)(=O)Nc1ccc2c(c1)CCN(c1cc(Cl)cc3[nH]ncc13)C2.Clc1cc(N2CCc3cnccc3C2)c2cn[nH]c2c1.
What is the InChIKey of N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline?
The InChIKey is MRPRBIZQNNYMSI-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17ClN4O2S.C17H21F3N4O2S.C16H21ClN4O2S.C15H13ClN4/c1-25(23,24)21-14-3-2-12-10-22(5-4-11(12)6-14)17-8-13(18)7-16-15(17)9-19-20-16;1-27(25,26)24-7-6-23(14-4-2-3-5-15(14)24)16-9-11(17(18,19)20)8-13-12(16)10-21-22-13;1-24(22,23)21-7-6-20(14-4-2-3-5-15(14)21)16-9-11(17)8-13-12(16)10-18-19-13;16-12-5-14-13(8-18-19-14)15(6-12)20-4-2-10-7-17-3-1-11(10)9-20/h2-3,6-9,21H,4-5,10H2,1H3,(H,19,20);8-10,14-15H,2-7H2,1H3,(H,21,22);8-10,14-15H,2-7H2,1H3,(H,18,19);1,3,5-8H,2,4,9H2,(H,18,19).
What are the key properties of N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline?
N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline has a molecular weight of 1432.95 g/mol, XLogP of 11.91, 8 rotatable bonds, 5 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-isoquinolin-6-yl]methanesulfonamide;2-(6-chloro-1H-indazol-4-yl)-3,4-dihydro-1H-2,6-naphthyridine;1-(6-chloro-1H-indazol-4-yl)-4-methylsulfonyl-2,3,4a,5,6,7,8,8a-octahydroquinoxaline;1-methylsulfonyl-4-[6-(trifluoromethyl)-1H-indazol-4-yl]-2,3,4a,5,6,7,8,8a-octahydroquinoxaline is sourced from PubChem (CID 159651412), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).